This content is in French.
Long-term efficacy of dapagliflozin in type 2 diabetes
13 février 2024
In this study, conducted between 2015 and 2020, the long-term efficacy of dapagliflozin on renal function and albuminuria in type 2 diabetic patients was evaluated. Study endpoints were changes in…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Gian Paolo Fadini et al. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk. Lancet Reg Health Eur. 2024 Feb 1:38:100847.
View the source
